POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 94 filers reported holding POSEIDA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,465,431 | +2.0% | 501,860 | +11.4% | 0.00% | – |
| Q1 2024 | $1,437,150 | -9.2% | 450,517 | -4.3% | 0.00% | – |
| Q4 2023 | $1,582,466 | +42.3% | 470,972 | +0.8% | 0.00% | – |
| Q3 2023 | $1,111,700 | +153.1% | 467,101 | +87.1% | 0.00% | – |
| Q2 2023 | $439,282 | -51.4% | 249,592 | -14.9% | 0.00% | – |
| Q1 2023 | $903,555 | +32.5% | 293,362 | +127.9% | 0.00% | – |
| Q4 2022 | $682,179 | +260273.7% | 128,713 | +73.6% | 0.00% | – |
| Q3 2022 | $262 | +125.9% | 74,144 | +65.8% | 0.00% | – |
| Q2 2022 | $116 | -100.0% | 44,715 | -20.8% | 0.00% | – |
| Q1 2022 | $253,000 | -52.4% | 56,477 | -27.5% | 0.00% | – |
| Q4 2021 | $531,000 | +27.6% | 77,932 | +36.3% | 0.00% | – |
| Q3 2021 | $416,000 | +20.6% | 57,175 | +65.9% | 0.00% | – |
| Q2 2021 | $345,000 | -8.0% | 34,457 | -12.2% | 0.00% | – |
| Q1 2021 | $375,000 | -18.7% | 39,249 | -6.6% | 0.00% | – |
| Q4 2020 | $461,000 | +43.2% | 42,025 | +15.9% | 0.00% | – |
| Q3 2020 | $322,000 | – | 36,272 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,043,267 | $11,445,000 | 1.96% |
| Pentwater Capital Management LP | 4,967,227 | $54,490,000 | 0.66% |
| SECTORAL ASSET MANAGEMENT INC | 838,826 | $9,202,000 | 0.65% |
| Vivo Capital, LLC | 926,447 | $10,163,000 | 0.45% |
| Boxer Capital, LLC | 1,251,055 | $13,724,000 | 0.44% |
| Ikarian Capital, LLC | 250,837 | $2,752,000 | 0.12% |
| Perceptive Advisors | 787,745 | $8,642,000 | 0.09% |
| Rock Springs Capital Management LP | 289,754 | $3,179,000 | 0.07% |
| Regent Investment Management LLC | 20,000 | $219,000 | 0.06% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,450,268 | $15,909,000 | 0.04% |